2015
DOI: 10.1534/genetics.115.181883
|View full text |Cite
|
Sign up to set email alerts
|

Targeted Chromosomal Translocations and Essential Gene Knockout Using CRISPR/Cas9 Technology in Caenorhabditis elegans

Abstract: Many genes play essential roles in development and fertility; their disruption leads to growth arrest or sterility. Genetic balancers have been widely used to study essential genes in many organisms. However, it is technically challenging and laborious to generate and maintain the loss-of-function mutations of essential genes. The CRISPR/Cas9 technology has been successfully applied for gene editing and chromosome engineering. Here, we have developed a method to induce chromosomal translocations and produce ge… Show more

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
4
1

Citation Types

0
34
0

Year Published

2016
2016
2021
2021

Publication Types

Select...
4
2

Relationship

1
5

Authors

Journals

citations
Cited by 32 publications
(34 citation statements)
references
References 51 publications
0
34
0
Order By: Relevance
“…This new nuclease was quickly used to induce chromosomal translocations, including the previously described models of NPM1-ALK (Ghezraoui et al, 2014) and Ewing sarcoma (Torres et al, 2014) (Renouf et al, 2014) and new models of lung cancer translocations (Choi and Meyerson, 2014) and acute myelogenous leukemia (Renouf et al, 2014; Torres et al, 2014). CRISPR-Cas9 was also used by other teams to create chromosomal translocations in mouse embryonic stem cells (Jiang et al, 2016) and in mouse myoblasts, the latter modeling the human alveolar rhabdyomyosarcoma Pax3-Foxo1 (Lagutina et al, 2015), but also in other organisms, namely C. elegans (Chen et al, 2015) and Leishmania (Zhang et al, 2017). …”
Section: The Crispr-cas9 Revolution: When Easy Is Made Easiermentioning
confidence: 99%
“…This new nuclease was quickly used to induce chromosomal translocations, including the previously described models of NPM1-ALK (Ghezraoui et al, 2014) and Ewing sarcoma (Torres et al, 2014) (Renouf et al, 2014) and new models of lung cancer translocations (Choi and Meyerson, 2014) and acute myelogenous leukemia (Renouf et al, 2014; Torres et al, 2014). CRISPR-Cas9 was also used by other teams to create chromosomal translocations in mouse embryonic stem cells (Jiang et al, 2016) and in mouse myoblasts, the latter modeling the human alveolar rhabdyomyosarcoma Pax3-Foxo1 (Lagutina et al, 2015), but also in other organisms, namely C. elegans (Chen et al, 2015) and Leishmania (Zhang et al, 2017). …”
Section: The Crispr-cas9 Revolution: When Easy Is Made Easiermentioning
confidence: 99%
“…Thereafter, large genomic fragments can be reversed, deleted, or translocated to other chromosomal loci. For example, our lab has reported the use of dual sgRNA strategy to direct reciprocal chromosomal translocations in C. elegans [58]. The nematode strains with specific chromosomal rearrangements can serve as genetic balancers for the screening and maintenance of essential genes [59].…”
Section: Introductionmentioning
confidence: 99%
“…It is pivotal to develop strategies to design sgRNAs with higher efficiency. The combination of multiple sgRNAs targeting the same gene was shown to improve cleavage efficiency [49, 58, 62]. Farboud and Meyer reported that guide RNAs with a GG motif at the 3′ end of their target sequences can dramatically improve the editing efficiency [63].…”
Section: Introductionmentioning
confidence: 99%
See 2 more Smart Citations